Trefoil factor 1 (pS2/TFF1), a peptide with numerous functions

被引:0
|
作者
Mathelin, C
Tomasetto, C
Rio, MC
机构
[1] Ctr Lutte Canc Paul Strauss, F-67085 Strasbourg, France
[2] Univ Strasbourg, F-67091 Strasbourg, France
[3] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France
关键词
TFF1; pS2; cancer; gut diseases; tumor suppressor gene; trefoil factor;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The trefoil factor (TFF) family includes three members : TFF1 also called pS2, TFF2 or spasmolytic peptide (SP) and TFF3 or intestinal trefoil factor (ITF). TFFs are associated with mucin-secreting epithelial cells and play a crucial role in mucosal defense and healing. In case of mucosa aggression (due to bacteria, virus or medication), inflammatory diseases and ulcerous pathology, they are involved in epithelium restitution and regeneration, In comparison with the other TFFs, pS2/TFF1 has particular junctions. Notably, it acts like a suppressor gene for gastric tumors, Evidence of pS2/TFF1 overexpression has been found in a range of carcinomas (breast. bowel, prostate, pancreas, thyroid, lung..). In breast cancer. pS2/TFF1 overexpression contributes to a favorable prognosis. Moreover, it is a predictive factor of hormonotherapy response.
引用
收藏
页码:773 / 781
页数:9
相关论文
共 50 条
  • [41] Trefoil factor family peptides TFF1 and TFF3 in the nervous tissues of developing mouse embryo
    Belovari, Tatjana
    Bijelic, Nikola
    Levak, Maja Tolusic
    Loncar, Mirela Baus
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2015, 15 (01) : 33 - 37
  • [42] The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS
    Calnan, DP
    Westley, BR
    May, FEB
    Floyd, DN
    Marchbank, T
    Playford, RJ
    JOURNAL OF PATHOLOGY, 1999, 188 (03): : 312 - 317
  • [43] Cytosolic levels of TFF1/pS2 in breast cancer:: their relationship with clinical-pathological parameters and their prognostic significance
    Corte, MD
    Tamargo, F
    Alvarez, A
    Rodríguez, JC
    Vázquez, J
    Sánchez, R
    Lamelas, ML
    González, LO
    Allende, MT
    García-Muñiz, JL
    Fueyo, A
    Vizoso, F
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 96 (01) : 63 - 72
  • [44] A Role for Methyl-CpG Binding Domain Protein 2 in the Modulation of the Estrogen Response of pS2/TFF1 Gene
    Chatagnon, Amandine
    Ballestar, Esteban
    Esteller, Manel
    Dante, Robert
    PLOS ONE, 2010, 5 (03):
  • [45] pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers
    Gillesby, BE
    Zacharewski, TR
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 56 (03) : 253 - 265
  • [46] pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers
    Bradley E. Gillesby
    Timothy R. Zacharewski
    Breast Cancer Research and Treatment, 1999, 56 (3) : 251 - 263
  • [47] Forced expression of Trefoil factor 1 (TFF1) in gastric carcinoma cells induces the expression of VEGF-A
    Muniraj, Nethaji
    Kannan, Nagarajan
    Grandison, Prudence
    Amiry, Naeem
    Dunand, Severine
    Perry, Jo
    Liu, Dongxu
    Lobie, Peter
    CANCER RESEARCH, 2009, 69
  • [48] The novel tumor suppressor Trefoil Factor Family 1 (TFF1) inhibits the development of hepatocellular carcinoma in mice
    Yamaguchi, Junpei
    Yokoyama, Yukihiro
    Kokuryo, Toshio
    Ebata, Tomoki
    Nagino, Masato
    HEPATOLOGY, 2017, 66 : 981A - 982A
  • [49] Trefoil peptide (pS2, hSp) expression in esophageal carcinomas
    Torres, C
    Turner, J
    Wang, H
    Shahsafaei, A
    Odze, R
    LABORATORY INVESTIGATION, 1996, 74 (01) : 376 - 376
  • [50] High expression of the trefoil protein TFF1 in interval breast cancers
    Crosier, M
    Scott, D
    Wilson, RG
    Griffiths, CDM
    May, FEB
    Westley, BR
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01): : 215 - 221